A Shigella sonnei clone with extensive drug resistance associated with waterborne outbreaks in China

Shaofu Qiu, Kangkang Liu, Chaojie Yang, Ying Xiang, Kaiyuan Min, Kunpeng Zhu, Hongbo Liu, Xinying Du, Mingjuan Yang, Ligui Wang, Yong Sun, Haijian Zhou, Muti Mahe, Jiayong Zhao, Shijun Li, Deshan Yu, Jane Hawkey, Kathryn E. Holt, Stephen Baker, Juntao YangXuebin Xu, Hongbin Song

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

Antimicrobial resistance of Shigella sonnei has become a global concern. Here, we report a phylogenetic group of S. sonnei with extensive drug resistance, including a combination of multidrug resistance, coresistance to ceftriaxone and azithromycin (cefRaziR), reduced susceptibility to fluoroquinolones, and even colistin resistance (colR). This distinct clone caused six waterborne shigellosis outbreaks in China from 2015 to 2020. We collect 155 outbreak isolates and 152 sporadic isolates. The cefRaziR isolates, including outbreak strains, are mainly distributed in a distinct clade located in global Lineage III. The outbreak strains form a recently derived monophyletic group that may have emerged circa 2010. The cefRaziR and colR phenotypes are attributed to the acquisition of different plasmids, particularly the IncB/O/K/Z plasmid coharboring the blaCTX-M-14, mphA, aac(3)-IId, dfrA17, aadA5, and sul1 genes and the IncI2 plasmid with an mcr-1 gene. Genetic analyses identify 92 accessory genes and 60 single-nucleotide polymorphisms associated with the cefRaziR phenotype. Surveillance of this clone is required to determine its dissemination and threat to global public health.

Original languageEnglish
Article number7365
Number of pages13
JournalNature Communications
Volume13
Issue number1
DOIs
Publication statusPublished - Dec 2022

Cite this